KRAS and cancer: The MassARRAY-based OncoFOCUS panel (v3) was previously adopted in our community pathology lab as a fully validated clinical test of common mutations in BRAF, EGFR, KIT, KRAS, and NRAS genes, which are implicated in various cancers, particularly colon cancer, lung cancer and melanoma.